课题基金 / 基金详情

13th Hershey Developmental Brain Injury Conference

13th Hershey Developmental Brain Injury Conference
第十三届好时发育性脑损伤会议
批准号:
10467344
负责人:
Sandra E Juul
金额:
$2.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-03-01 至 2023-02-28

项目摘要

项目成果

Sandra E Juul的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT The Hershey Conference on Developmental Brain Injury was started in 1997 and has grown to a high-quality program that attracts international attendees that include physician-scientists, basic scientists, and trainees. The conference is held every other year, and the site alternates between international and US locations. Sessions include invited speakers who are luminaries in the field, as well as sessions in which more junior investigators share their work. This conference offers an amazing opportunity for trainees and young investigators to meet and interact with senior investigators in the field in a relaxed environment. The scientific presentations are always outstanding. The 2022 13th Hershey Conference organized by Drs. Sandra Juul, Elizabeth Nance and Thomas Wood will be held in the Pacific Northwest, outside of Seattle Washington at the Alderbrook Resort and Spa. We are applying to NIH for support primarily to fund attendance for junior investigators and trainees. The overall goal of the proposed meeting is to bring together an international group of scientists whose focus is on neonatal brain injury and repair. This year’s overarching theme will be: Effects of the environment on prevalence and outcomes of developmental brain injury. This three-day meeting will include the following sessions: Long-term consequences of developmental brain injury; Brain aging and susceptibility to second hit events; Epigenetic and microbiome effects; Mechanisms and cellular imaging and Societal; environmental, and systemic effects on premature/LBW. The meeting has four objectives: 1) To identify clinical paradigms that inform basic science concepts and translate those new basic concepts into more refined clinical application 2) To explore areas of gaps in our current knowledge, and to include experts in tangential fields to provide new perspectives on these gaps 3) To promote novel collaborations 4) To promote trainee and junior faculty participation and to identify trainees/junior faculty from racial/ethnic minorities and underrepresented institutions to attend this conference and develop new collaborations. In summary, the objective of this R13 is to provide the necessary continued support for trainees and junior faculty to attend the 13th Hershey Conference on Developmental Brain Injury. Extensive participation of trainees, both from US and abroad, has been a hallmark of the Hershey Conference. Trainees, both MD and PhD, constitute 30-40% of all participants. This meeting provides an excellent opportunity for informal interaction between trainees and the leaders in the field as well as a mechanism for post-doctoral and visiting scientist recruitment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Trial of Darbepoetin plus slow-release intravenous iron to decrease transfusions and improve iron status and neurodevelopment in preterm infants
  • 批准号:
    10662182
  • 项目类别:
  • 资助金额:
    $56.38万
  • 财政年份:
    2022
  • 负责人:
    Sandra E Juul
  • 依托单位:
Trial of Darbepoetin plus slow-release intravenous iron to decrease transfusions and improve iron status and neurodevelopment in preterm infants
  • 批准号:
    10340574
  • 项目类别:
  • 资助金额:
    $49.23万
  • 财政年份:
    2022
  • 负责人:
    Sandra E Juul
  • 依托单位:
Intellectual and Developmental Disabilities Research Center
  • 批准号:
    10661668
  • 项目类别:
  • 资助金额:
    $127.18万
  • 财政年份:
    2020
  • 负责人:
    Sandra E Juul
  • 依托单位:
High-dose Erythropoietin for Asphyxia and Encephalopathy (HEAL) CCC
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: